Page 29 - IMCJ19s1
P. 29

32.  Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, et al. Induction of pro-inflammatory
            Acknowledgements                                     cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-
            The authors wish to acknowledge the substantial conceptual contributions provided   CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 Mar 14;34(2). pii:
                                                                 1.
            by Neil Alexis, PhD, professor of pediatrics, Director of the Applied Immunobiology   33.  Chen  IY,  Moriyama  M,  Chang  MF,  Ichinohe  T.  Severe  Acute  Respiratory  Syndrome
            Laboratory at UNC Chapel Hill, and PI of the Human Sample Biorepository at the   Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome. Front Microbiol. 2019 Jan
            UNC CEMALB. The authors also wish to acknowledge Laurie A. Hofmann, MPH,   29;10:50.
            immediate past Chairwoman and Chief Executive Officer, Institute for Functional   34.  Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and
            Medicine, for convening the group that led to the development of this paper.  corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience.
                                                                 2020; 14: 1023.
                                                              35.  Leemans  JC,  Kors  L,  Anders  HJ,  Florquin  S.  Pattern  recognition  receptors  and
            Author Disclosure Statement                          the inflammasome in kidney disease. Nat Rev Nephrol. 2014 Jul;10(7):398-414.
            The authors declare no conflicts of interest.     36.  Li,  S.,  Wang,  C.,  Jou,  Y.  et  al.  SARS  coronavirus  papain-like  protease  induces  Egr-1-
                                                                 dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway. Sci Rep 2016 6,
                                                                 25754.
                                                              37.  Artlett  CM.  The  Role  of  the  NLRP3  Inflammasome  in  Fibrosis.  Open Rheumatol J.
            References                                           2012;6:80-6.
             1.  Prompetchara  E,  Ketloy  C,  Palaga  T.  Immune  responses  in  COVID-19  and  potential   38.  Liu  RM,  Gaston  Pravia  KA.  Oxidative  stress  and  glutathione  in  TGF-beta-mediated
               vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol.   fibrogenesis. Free Radic Biol Med. 2010 Jan 1;48(1):1-15.
               2020 Mar;38(1):1-9.                            39.  Anathy V, Lahue KG, Chapman DG, Chia SB, Casey DT, et al. Reducing protein oxidation
             2.  Tan L, Wang Q, Zhang D, Ding J, Huang Q, et al. Lymphopenia predicts disease severity of   reverses lung fibrosis. Nat Med. 2018 Aug;24(8):1128-1135.
               COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020 Mar   40.  Donath MY. When metabolism met immunology. Nat Immunol. 2013 May;14(5):421-2.
               27;5:33.                                       41.  Liston  A,  Masters  SL.  Homeostasis-altering  molecular  processes  as  mechanisms  of
             3.  Wang,  X.,  Xu,  W.,  Hu,  G.  et al.  SARS-CoV-2  infects  T  lymphocytes  through  its  spike   inflammasome activation. Nat Rev Immunol. 2017 Mar;17(3):208-214.
               protein-mediated membrane fusion. Cell Mol Immunol (2020).  42.  Ozkurede VU, Franchi L. Immunology in clinic review series; focus on autoinflammatory
             4.  Chu,  H.  et  al.  Middle  east  respiratory  syndrome  coronavirus  efficiently  infects  human   diseases: role of inflammasomes in autoinflammatory syndromes. Clin Exp Immunol. 2012
               primary  T  lymphocytes  and  activates  the  extrinsic  and  intrinsic  apoptosis  pathways.  J.   Mar;167(3):382-90.
               Infect. Dis. 213, 904–914 (2016).              43.  Doria  A,  et  al.  Autoinflammatory  diseases:  how  to  put  the  fire  inside  the  body  out?
             5.  Channappanavar  R,  Fehr  AR,  Vijay  R,  Mack  M,  Zhao  J,  Meyerholz  DK,  Perlman  S.   Autoimmun Rev. 2012 Nov;12(1):1-4.
               Dysregulated  Type  I  Interferon  and  Inflammatory  Monocyte-Macrophage  Responses   44.  Doria A, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev.
               Cause  Lethal  Pneumonia  in  SARS-CoV-Infected  Mice.  Cell Host Microbe.  2016  Feb   2012 Nov;12(1):22-30.
               10;19(2):181-93.                               45.  Zhang Y, Xiao M, Zhang S, Zhang S, Li Y. Coagulopathy and Antiphospholipid Antibodies
             6.  COVID-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922.  in Patients with COVID-19. NEJM, 4.8.20. [Prepublication]. DOI: 10.1056/NEJMc2007575.
             7.   Luster, AD. Chemokines – Chemotactic Cytokines that Mediate Inflammation. N Engl J   46.  Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19
               Med. 1998 Feb 12;338(7):436-45.                   associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-
             8.  Barnes  P,  Karin  M.  Nuclear  factor-kB  —  a  pivotal  transcription  factor  in  chronic   422.
               inflammatory diseases. N Engl J Med. 1997 Apr 10;336(15):1066-71.  47.  Considerable  mucus  found  in  small  airways  of  COVID-19  patients:  expert.  XinhuaNet
             9.  Soehnlein  O,  Lindbom  L.  Phagocyte  partnership  during  the  onset  and  resolution  of   2020-02-27 14:39:47.
               inflammation. Nat Rev Immunol. 2010 Jun;10(6):427-39.   48.  Cheng OZ1, Palaniyar N. NET balancing: a problem in inflammatory lung diseases. Front
             10.  Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B. Comorbidities and multi-organ injuries   Immunol. 2013 Jan 24;4:1.
               in the treatment of COVID-19. Lancet. 2020 Mar 21;395(10228):e52.  49.  Ebrahimi F, Giaglis S, Hahn S, Blum CA, Baumgartner C, Kutz A. Markers of neutrophil
             11.  Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes.   extracellular traps predict adverse outcome in community-acquired pneumonia: secondary
               Mol Med. 2012 Feb 10;18:123-37.                   analysis of a randomised controlled trial. Eur Respir J. 2018 Apr 26;51(4). pii: 1701389.
             12.  Pinkerton JW, Kim RY, Robertson AAB, et al. Inflammasomes in the lung. Mol Immunol.   50.  Kaplan  MJ,  Radic  M.  Neutrophil  extracellular  traps:  double-edged  swords  of  innate
               2017 Jun;86:44-55.                                immunity. J Immunol. 2012 Sep 15;189(6):2689-95.
             13.  Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with   51.  Elaskalani  O,  Abdol  Razak  NB,  Metharom  P.  Neutrophil  extracellular  traps  induce
               2019 coronavirus disease in China. Pediatrics. In press.  aggregation of washed human platelets independently of extracellular DNA and histones.
             14.  Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with   Cell Commun Signal. 2018 May 29;16(1):24.
               2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506.  52.  Stoiber W, Obermayer A, Steinbacher P, Krautgartner WD. The Role of Reactive Oxygen
             15.  Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of   Species (ROS) in the Formation of Extracellular Traps (ETs) in Humans. Biomolecules. 2015
               adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet   May 4;5(2):702-23.
               2020; 395: 1054–62.                            53.  Fadini GP, Menegazzo L, Scattolini V, Gintoli M, Albiero M, Avogaro A. A perspective on
             16.  Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact   NETosis  in  diabetes  and  cardiometabolic  disorders.  Nutr  Metab  Cardiovasc  Dis.  2016
               on 1590 patients with COVID-19 in China: A Nationwide Analysis. Eur Respir J. 2020 Mar   Jan;26(1):1-8.
               26. pii: 2000547.                              54.  Kimball AS, Obi AT, Diaz JA, Henke PK. The Emerging Role of NETs in Venous Thrombosis
             17.  Brauer M. How much, how long, what, and where: air pollution exposure assessment for   and Immunothrombosis. Front Immunol. 2016 Jun 27;7:236.
               epidemiologic studies of respiratory disease. Proc Am Thorac Soc. 2010 May;7(2):111-5.   55.  Saffarzadeh  M,  Juenemann  C,  Queisser  MA,  Lochnit  G,  Barreto  G,  Galuska  SP,  et  al.
             18.  Wooding DJ, Ryu MH, Li H, Alexis NE, Pena O, Carlsten C. Acute air pollution exposure   Neutrophil  extracellular  traps  directly  induce  epithelial  and  endothelial  cell  death:  a
               alters neutrophils in never-smokers and at-risk humans. Eur Respir J. 2020 Apr 3;55(4). pii:   predominant role of histones. PLoS One. 2012;7(2):e32366.
               1901495.                                       56.  Xu J1, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL,
             19.  Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary Pathology of Early-Phase 2019   Lupu F, Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med.
               Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac   2009 Nov;15(11):1318-21.
               Oncol. 2020 Feb 28. pii: S1556-0864(20)30132-5.  57.  Lipinska-Gediga M. Neutrophils, NETs, NETosis - old or new factors in sepsis and septic
             20.  Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. Lille Intensive   shock? Anaesthesiol Intensive Ther. 2017;49(3):235-240.
               Care  COVID-19  and  Obesity  study  group.  High  prevalence  of  obesity  in  severe  acute   58.  Zawrotniak  M,  Kozik  A,  Rapala-Kozik  M.  Selected  mucolytic,  anti-inflammatory  and
               respiratory  syndrome  coronavirus-2  (SARS-CoV-2)  requiring  invasive  mechanical   cardiovascular drugs change the ability of neutrophils to form extracellular traps (NETs).
               ventilation. Obesity (Silver Spring). 2020 Apr 9.  Acta Biochim Pol. 2015;62(3):465-73.
             21.  Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity   59.  Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein
               (Silver Spring). 2020 Apr 1.                      thrombosis. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83.
             22.  Furman  D,  Chang  J,  Lartigue  L,  Bolen  CR,  Haddad  F,  et  al.  Expression  of  specific   60.  Fuchs  TA,  Brill  A,  Duerschmied  D,  Schatzberg  D,  Monestier  M,  Myers  DD  Jr,  et  al.
               inflammasome  gene  modules  stratifies  older  individuals  into  two  extreme  clinical  and   Extracellular  DNA  traps  promote  thrombosis.  Proc Natl Acad Sci U S A.  2010  Sep
               immunological states. Nat Med. 2017 Feb;23(2):174-184.   7;107(36):15880-5.
             23.  Strowig  T,  Henao-Mejia  J,  Elinav  E,  Flavell  R.  Inflammasomes  in  health  and  disease.   61.  Joshi MB, Lad A, Bharath Prasad AS, Balakrishnan A, Ramachandra L, Satyamoorthy K.
               Nature. 2012 Jan 18;481(7381):278-86.             High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil
             24.  Leemans  JC,  Kors  L,  Anders  HJ,  Florquin  S.  Pattern  recognition  receptors  and  the   extracellular trap formation. FEBS Lett. 2013 Jul 11;587(14):2241-6.
               inflammasome in kidney disease. Nat Rev Nephrol. 2014 Jul;10(7):398-414.  62.  Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe
             25.  Szabo  G,  Petrasek  J.  Inflammasome  activation  and  function  in  liver  disease.  Nat Rev   COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to
               Gastroenterol Hepatol. 2015 Jul;12(7):387-400.    reduce the mortality. Int J Antimicrob Agents. 2020 Mar 29:105954.
             26.  Im  H,  Ammit  AJ.  The  NLRP3  inflammasome:  role  in  airway  inflammation.  Clin Exp   63.  Pedersen F, Waschki B, Marwitz S, Goldmann T, Kirsten A, et al. Neutrophil extracellular
               Allergy. 2014 Feb;44(2):160-72.                   trap  formation  is  regulated  by  CXCR2  in  COPD  neutrophils.  Eur Respir J.  2018  Apr
             27.  Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, et al. Induction of pro-inflammatory   12;51(4). pii: 1700970.
               cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-  64.  Hernandez ML, Mills K, Almond M, Todoric K, Aleman MM, Zhang H, et al. IL-1 receptor
               CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 Mar 14;34(2). pii: 1.   antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. J Allergy
             28.  Alhazzani  W,  Møller  MH,  Arabi  YM,  Loeb  M,  Gong  MN,  Fan  E,  et  al.  Surviving  Sepsis   Clin Immunol. 2015 Feb;135(2):379-85.
               Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease   65.  Sauaia A, Moore FA, Moore EE. Postinjury Inflammation and Organ Dysfunction. Crit
               2019 (COVID-19). Crit Care Med. 2020 Mar 27.      Care Clin. 2017 Jan;33(1):167-191.
             29.  Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of Coronavirus Disease 2019   66.  Irwin MR1. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol.
               (COVID-19)  With  Myocardial  Injury  and  Mortality.  JAMA  Cardiol.  Published  online   2019 Nov;19(11):702-715.
               March 27, 2020.                                67.  Marsland  AL,  Walsh  C,  Lockwood  K,  John-Henderson  NA.  The  effects  of  acute
             30.  Zhang Y, Xiao M, Zhang S, Zhang S, Li Y. Coagulopathy and Antiphospholipid Antibodies   psychological  stress  on  circulating  and  stimulated  inflammatory  markers:  a  systematic
               in Patients with COVID-19. NEJM, 4.8.20. [Prepublication]. DOI: 10.1056/NEJMc2007575  review and meta-analysis. Brain Behav Immun (2017) 64:208–19.
             31.  Giwa  AL,  Desai  A,  Duca  A.  Novel  2019  coronavirus  SARS-CoV-2  (COVID-19):  An   68.  Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, et al. Chronic stress,
               updated overview for emergency clinicians. Emerg Med Pract. 2020 May 1;22(5):1-28. Epub   glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci USA
               2020 Mar 24.                                      (2012) 109(16):5995–9.
            Yanuck—Immuno-physiological Approach to COVID-19         Integrative Medicine • Vol. 19, No. S1 • Epub Ahead of Print  27
   24   25   26   27   28   29   30   31   32   33   34